Use este identificador para citar ou linkar para este item:
http://repositorio.ufla.br/jspui/handle/1/41296Registro completo de metadados
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.creator | Ghosh, Amerta | - |
| dc.creator | Gupta, Ritesh | - |
| dc.creator | Misra, Anoop | - |
| dc.date.accessioned | 2020-06-01T16:03:42Z | - |
| dc.date.available | 2020-06-01T16:03:42Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | GHOSH, A.; GUPTA, R.; MISRA, A. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, [S.l.], v. 14, n. 4, p. 273-276, July/Aug. 2020. | pt_BR |
| dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S1871402120300606 | pt_BR |
| dc.identifier.uri | http://repositorio.ufla.br/jspui/handle/1/41296 | - |
| dc.description.abstract | Background and aims In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. Methods PubMed and Google Scholar search engines were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19 up to 31st March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed. Results We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. Conclusions Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required. | pt_BR |
| dc.language | en_US | pt_BR |
| dc.publisher | Elsevier | pt_BR |
| dc.rights | restrictAccess | pt_BR |
| dc.source | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | pt_BR |
| dc.subject | COVID-19 | pt_BR |
| dc.subject | Diabetes | pt_BR |
| dc.subject | Telemedicine | pt_BR |
| dc.title | Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: guidelines for physicians | pt_BR |
| dc.type | Artigo | pt_BR |
| Aparece nas coleções: | FCS - Artigos sobre Coronavirus Disease 2019 (COVID-19) | |
Arquivos associados a este item:
Não existem arquivos associados a este item.
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.